LIFEVANTAGE CORP Increase (Decrease) in Deposit Assets
LIFEVANTAGE CORP (LFVN) reported Increase (Decrease) in Deposit Assets of $1.17 million for the 12-month period ending 2013-06-30, per its 10-K filed 2013-09-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2013-09-12
- LIFEVANTAGE CORP increase (decrease) in deposit assets for the quarter ending 2013-06-30 was $91.00K, a 70.65% decline year-over-year.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for the quarter ending 2013-03-31 was -$106.00K.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for the quarter ending 2012-12-31 was -$62.00K.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for the quarter ending 2012-09-30 was $1.25M, a 1975.00% increase year-over-year.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for fiscal 2013 was $1.17M, a 276.77% increase from fiscal 2012.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for fiscal 2012 was $310.00K, a 7650.00% increase from fiscal 2011.
- LIFEVANTAGE CORP increase (decrease) in deposit assets for fiscal 2011 was $4.00K.
| Period end | Increase (Decrease) in Deposit Assets 3 month | Increase (Decrease) in Deposit Assets 6 month | Increase (Decrease) in Deposit Assets 9 month | Increase (Decrease) in Deposit Assets 12 month | Increase (Decrease) in Deposit Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2013-06-30 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | -$15.00K derived: sum of 2 quarters · filed 2013-09-12 | -$77.00K derived: sum of 3 quarters · filed 2013-09-12 | $1.17M 10-K · filed 2013-09-12 | |
| 2013-03-31 | -$106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | -$168.00K derived: sum of 2 quarters · filed 2013-05-09 | $1.08M 10-Q · filed 2013-05-09 | $1.39M derived: sum of 4 quarters · filed 2013-09-12 | |
| 2012-12-31 | -$62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-07 | $1.18M 10-Q · filed 2013-02-07 | $1.49M derived: sum of 3 quarters · filed 2013-09-12 | $1.43M derived: sum of 4 quarters · filed 2013-09-12 | |
| 2012-09-30 | $1.25M 10-Q · filed 2012-11-08 | $1.55M derived: sum of 2 quarters · filed 2013-09-12 | $1.50M derived: sum of 3 quarters · filed 2013-09-12 | $1.50M derived: sum of 4 quarters · filed 2013-09-12 | |
| 2012-06-30 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | $250.00K derived: sum of 2 quarters · filed 2013-09-12 | $250.00K derived: sum of 3 quarters · filed 2013-09-12 | $310.00K 10-K · filed 2013-09-12 | $309.93K 10-K · filed 2012-09-10 |
| 2012-03-31 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | -$60.00K derived: sum of 2 quarters · filed 2013-05-09 | $0.00 10-Q · filed 2013-05-09 | ||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-07 | $60.00K 10-Q · filed 2013-02-07 | |||
| 2011-09-30 | $60.00K 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | $4.00K 10-K · filed 2013-09-12 | $3.56K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |